pioglitazone has been researched along with sb 216763 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartolini, M; Bolognesi, ML; Campillo, NE; Castellano, S; Feoli, A; Gandini, A; Legname, G; Martinez, A; Martinez-Gonzalez, L; Miti, A; Moda, F; Monti, B; Perez, C; Petralla, S; Roca, C; Rossi, M; Tedesco, D; Zaldivar-Diez, J; Zuccheri, G | 1 |
1 other study(ies) available for pioglitazone and sb 216763
Article | Year |
---|---|
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors.
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Central Nervous System Agents; Circular Dichroism; Drug Design; Drug Evaluation, Preclinical; Fluorescence Resonance Energy Transfer; Glycogen Synthase Kinase 3; Hep G2 Cells; Humans; Microscopy, Atomic Force; Molecular Targeted Therapy; Okadaic Acid; Phosphorylation; Protein Kinase Inhibitors; Rats; Structure-Activity Relationship; Swine; tau Proteins; Thiazolidinediones | 2018 |